Vistogard Granule
Product Images NDC 50633-220

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Vistogard (NDC 50633-220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Btg International Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Vistogard 01)

FDA Label Image

Principal Display Panel (10 g Packet Carton)

Principal Display Panel (10 g Packet Carton)
This text provides information about VISTOGARD® 10g (uridine triacetate) oral granules, which come in a carton containing 20 x 10 gram packets. The granules should be mixed into soft food before administration and each dose requires one packet. The usual dosage and storage instructions are also provided. Additionally, it mentions the manufacturer, BTG International Inc., and that the product is made in the UK.*
FDA Label Image

Principal Display Panel (10 g Packet Carton)

Principal Display Panel (10 g Packet Carton)
This is a description of Vistogard'10 oral granules containing uridine triacetate. Each carton contains 4 packets, with each single-dose packet containing 10g of uridine triacetate. The directions for use recommend mixing each dose into soft food prior to administration. The usual dosage instructions can be found in the prescribing information. It is advised to store the medication at 25°C with excursions up to 15-30°C permitted. This medication should be kept out of reach of children and unused portions of granules should be discarded as per the instructions.*
FDA Label Image

Principal Display Panel (10 g Sachet Foil)

Principal Display Panel (10 g Sachet Foil)
This text provides information regarding Vistogard® (uridine triacetate) oral granules. Each single-dose packet contains 10 g of uridine triacetate meant for administration by mixing it into a soft food like applesauce, pudding, or yogurt. It emphasizes storing the medication at 25°C with excursions permitted within the range of 15-30°C. The manufacturing and distribution details are provided for BTG International Inc., located in West Conshohocken, PA, USA. Additionally, the pharmaceutical formulation is made in the UK. The text also highlights the importance of keeping the medication out of reach of children and advises consulting the prescribing information for dosage details.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.